Fishbein Skye R S, Tomasi Francesca G, Wolf Ian D, Dulberger Charles L, Wang Albert, Keshishian Hasmik, Wallace Luke, Carr Steven A, Ioerger Thomas R, Rego E Hesper, Rubin Eric J
Department of Immunology and Infectious Disease, Harvard TH Chan School of Public Health, Boston, Massachusetts, 02115, United States.
Broad Institute of MIT and Harvard, Cambridge, 02142, United States.
J Bacteriol. 2020 Dec 23;203(6). doi: 10.1128/JB.00604-20.
The recalcitrance of mycobacteria to antibiotic therapy is in part due to its ability to build proteins into a multi-layer cell wall. Proper synthesis of both cell wall constituents and associated proteins is crucial to maintaining cell integrity, and intimately tied to antibiotic susceptibility. How mycobacteria properly synthesize the membrane-associated proteome, however, remains poorly understood. Recently, we found that loss of in (Msm) altered tolerance to rifampin, a drug that targets a non-ribosomal cellular process. LepA is a ribosome-associated GTPase found in bacteria, mitochondria, and chloroplasts, yet its physiological contribution to cellular processes is not clear. To uncover the determinants of LepA-mediated drug tolerance, we characterized the whole-cell proteomes and transcriptomes of a deletion mutant relative to strains with We find that LepA is important for the steady-state abundance of a number of membrane-associated proteins, including an outer membrane porin, MspA, which is integral to nutrient uptake and drug susceptibility. Loss of LepA leads to a decreased amount of porin in the membrane which leads to the drug tolerance phenotype of the mutant. In mycobacteria, the translation factor LepA modulates mycobacterial membrane homeostasis, which in turn affects antibiotic tolerance.The mycobacterial cell wall is a promising target for new antibiotics due to the abundance of important membrane-associated proteins. Defining mechanisms of synthesis of the membrane proteome will be critical to uncovering and validating drug targets. We found that LepA, a universally conserved translation factor, controls the synthesis of a number of major membrane proteins in LepA primarily controls synthesis of the major porin MspA. Loss of LepA results in decreased permeability through the loss of this porin, including permeability to antibiotics like rifampin and vancomycin. In mycobacteria, regulation from the ribosome is critical for the maintenance of membrane homeostasis and, importantly, antibiotic susceptibility.
分枝杆菌对抗生素治疗的顽固性部分归因于其将蛋白质构建到多层细胞壁中的能力。细胞壁成分和相关蛋白质的正确合成对于维持细胞完整性至关重要,并且与抗生素敏感性密切相关。然而,分枝杆菌如何正确合成膜相关蛋白质组仍知之甚少。最近,我们发现耻垢分枝杆菌(Msm)中lepA的缺失改变了对利福平的耐受性,利福平是一种针对非核糖体细胞过程的药物。LepA是一种在细菌、线粒体和叶绿体中发现的核糖体相关GTP酶,但其对细胞过程的生理贡献尚不清楚。为了揭示LepA介导的药物耐受性的决定因素,我们对lepA缺失突变体相对于野生型菌株的全细胞蛋白质组和转录组进行了表征。我们发现LepA对于许多膜相关蛋白的稳态丰度很重要,包括外膜孔蛋白MspA,它对于营养物质摄取和药物敏感性不可或缺。LepA的缺失导致膜中孔蛋白数量减少,从而导致lepA突变体的药物耐受表型。在分枝杆菌中,翻译因子LepA调节分枝杆菌膜稳态,进而影响抗生素耐受性。由于存在大量重要的膜相关蛋白,分枝杆菌细胞壁是新型抗生素的一个有前景的靶点。定义膜蛋白质组合成的机制对于发现和验证药物靶点至关重要。我们发现,普遍保守的翻译因子LepA控制耻垢分枝杆菌中许多主要膜蛋白的合成。LepA主要控制主要孔蛋白MspA的合成。LepA的缺失导致由于该孔蛋白的丧失而通透性降低,包括对利福平和万古霉素等抗生素的通透性。在分枝杆菌中,核糖体的调节对于维持膜稳态以及重要的抗生素敏感性至关重要。